• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Supporting Musculoskeletal Health: Tending to Muscles, Joints, and Bones

    2023 Contract Manufacturing Survey

    Dosage and Delivery Innovations Help Manufacturers Meet Common Challenges

    A Paradigm Shift for Antioxidants?

    Manufacturing Dietary Supplements in Economic Uncertainty
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Glossary
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    NPA: ‘Major Victory’ in Colorado After Amendment to Eating Disorder Bill

    GOOD Meat Receives FDA Go-Ahead for Cultured Meat

    IFF Achieves Industrial-Scale Production of Anaerobic Probiotic Strain

    Jones Healthcare Group Primed to Help Nutraceutical Brands Comply with New Packaging Rules

    Nordic Naturals Debuts Probiotic Line in More Than 375 Sprouts Farmer’s Markets
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Harmonizing the EU's Upper Limits For Micronutrients

    GOOD Meat Receives FDA Go-Ahead for Cultured Meat

    IFF Achieves Industrial-Scale Production of Anaerobic Probiotic Strain

    Nordic Naturals Debuts Probiotic Line in More Than 375 Sprouts Farmer’s Markets

    DolCas Biotech's Curcugen Featured in Beauty-From-Within Supplement
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    NPA: ‘Major Victory’ in Colorado After Amendment to Eating Disorder Bill

    Harmonizing the EU's Upper Limits For Micronutrients

    GOOD Meat Receives FDA Go-Ahead for Cultured Meat

    IFF Achieves Industrial-Scale Production of Anaerobic Probiotic Strain

    Jones Healthcare Group Primed to Help Nutraceutical Brands Comply with New Packaging Rules
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    NPA: ‘Major Victory’ in Colorado After Amendment to Eating Disorder Bill

    Nordic Naturals Debuts Probiotic Line in More Than 375 Sprouts Farmer’s Markets

    DolCas Biotech's Curcugen Featured in Beauty-From-Within Supplement

    NOW Tests Bromelain Supplements Purchased on Amazon

    Podcast: Erin Stokes, ND, on Natural Health Strategies and the Role for Dietary Supplements
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    American FlexPack

    Xsto Solutions

    BGG Americas, Inc.

    Nutrition21, LLC

    PhytoGaia Inc
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    American FlexPack

    Xsto Solutions

    BGG Americas, Inc.

    Nutrition21, LLC

    PhytoGaia Inc
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Political Disruption Presents Opportunity for Industry

    How can the regulatory framework be improved in order to benefit business and consumers?

    Political Disruption Presents  Opportunity for Industry
    Todd Harrison, Venable04.03.17
    The U.S. election in November was certainly a surprise and ended one of the most controversial and disruptive elections in recent memory. The aftermath has been even more disruptive. Indeed, we have rarely seen a president so committed to being disruptive, and if the first three months of the Trump presidency are any indication, these trends will continue.

    Having the federal bureaucracy shaken up may or may not be good news to individuals or companies, but there is little doubt that disruption can either be positive or negative. Certainly, overly burdensome or nonsensical regulatory schemes are of themselves disruptive, especially if they deny access to products that promote overall health and well-being. In this regard, the present regulatory structure for dietary supplements and topical products is disruptive to the overall health and well-being of consumers in the U.S. 

    With regard to dietary supplements, the passage of the Dietary Supplement Health and Education Act (DSHEA) was considered disruptive legislation that tied the hands of the FDA. This myth persists today. The reality, however, is that over the last 22-plus years, this legislation has become more of a negative disruption by creating a construct that has left very few barriers of entry, stymied innovation—as FDA has learned it has considerable power under DSHEA—and left consumers with less information regarding how to better their overall health.

    Even worse, it creates a situation where it compels company lawyers to push the limits of credulity of the medical food category. Seriously, does anyone believe that individuals with osteoarthritis have a unique nutritional need for polyphenols? Does anyone earnestly believe “helps reduce the appearance of wrinkles” is any different than simply stating “helps reduces wrinkles”? Furthermore, does the claim “helps support normal blood sugar levels,” rather than “helps support already normal blood sugar levels,” make any sense? Does anyone believe that a simple change in the manufacturing method causes a pre-DSHEA dietary ingredient to, suddenly, become a “new” dietary ingredient? Or that changing a standardization level so the dietary supplement can be taken in one large pill, rather than one small pill, cause that ingredient to become a new dietary ingredient?

    Yet, this is exactly what the present regulatory framework does. Does anyone seriously believe that after 22 years, FDA can effectively determine what was on the market prior to Oct. 14, 1994 when documents were stored in boxes and not on computer networks? Should any regulator be able to ask for all the information substantiating a claim and then simply state “our experts disagree” and attempt to force a consent judgment down a company’s throat, because the company cannot make a solid evaluation of the regulator’s evidence? Yet, that is the FTC and state investigatory practice. They take all the information in and the target company gets no feedback. Simply stated, we have a disruptive regulatory state in the natural products industry. I will spare everyone my diatribe on class action lawsuits.  

    Dysfunctional Framework
    These are just a few of the points that a negative disruptive regulatory framework brings to us. Indeed, one could say to be careful what you ask for because you may very well get it. Well, 22-plus years later we have a dysfunctional regulatory framework that wreaks havoc in the marketplace. It deprives consumers of important information regarding a product, because we’ve decided that many of the following purported age-related issues are diseases, including, prediabetes, metabolic syndrome osteoarthritis, obesity, BPH, prehypertension, and, yes, even diabetes and hypertension that do not require medication to control. A natural topical product cannot even say “soothes diaper rash” if it doesn’t contain one of the enumerated topical OTC drugs for the treatment of diaper rash. Yet, products making these claims are readily available on the Internet. Many of them are legitimate yet others are sold by unscrupulous marketers that prey on the ignorance of consumers and stay ahead of federal and state agencies while creating a substantial stain on the natural products industry.

    Unfortunately, we have developed a regulatory system that fails to recognize that natural medicine helps individuals whether the product is ingested or applied topically. Instead, we have created a system that demands expensive clinical trials for ingredients that are no longer patentable because their uses are not novel, making it unlikely such a trial will be conducted. It is a system in which courts are now allowing plaintiff attorneys to file lawsuits under state deceptive trade practices if a particular structure/function or cosmetic claim might be considered a disease claim based on the preamble to a final rule or an FDA warning letter. This is true even if the company receiving the warning letter has a legitimate position that the claim is not an impermissible disease claim.

    Examples include “helps alleviate sore joints” and “helps alleviate nighttime trips in men over the age of 50” in which both claims are related to the natural progression of age. The central fact here is that as we age, our joints ache. It is part of life, but we treat it as if it were a disease. For men over 50, getting up once or twice nightly is not uncommon, and is part of the well-accepted fact that prostates grow at this stage in life. Yet, it is perceived as a disease. It is a system that has not kept up with what the public wants and legitimate companies can provide. 

    Innovation and legitimate products have become beholden to the constraints of the regulatory system and a heavy reliance on lawyers to bend and twist words to help communicate the real purpose of the product without running afoul of the system. It has created a vast number of gray areas between what is and what is not a permissible claim. We use claims such as “helps support blood pressure already in the normal range” when, in fact, if you have 120/80 blood pressure you do not need this product. However, if you are pre-hypertensive or at stage 1 where dietary intervention and exercise is always the initial intervention, including use of targeted dietary supplements that can help lower blood pressure sensitive to dietary intervention, this claim cannot be communicated to consumers by a company.

    Probably, the more absurd situation I alluded to previously is topical natural products that cannot even make the claim “helps soothe diaper rash” unless it contains specific permitted active ingredients covered by the OTC Drug Monograph system. This makes little sense and is a waste of FDA’s enforcement time to take issue with such products, especially if the claims are substantiated.

    Suggestions for Positive Disruption
    By now you are asking, “How does this relate to the disruptive results of the national election?  Todd, we know the regulatory system is screwed up and it’s not, necessarily, the fault of the regulators.” My point is that for the first time in a very long time, we have an administration that is open to true, positive disruption, and the industry should be thinking how to put a more sane regulatory system in place for both dietary supplements and topical natural products.

    We could create a natural product monograph system and specifically preclude class action lawsuits on claims that are consistent with that monograph. For those products that don’t fit into the monograph, there should be the option to conduct a clinical study on the product, and if the results are positive, the claims should be permissible. We could setup a 510k-like system, as we currently have for medical devices, but for natural products. FDA could review the study and agree whether the study supports the claim. Within this system, we could create a process in which FDA reviews the protocol of the study first (for a reasonable fee), provides feedback, and ultimately signs off on the study design.

    It should not be required to undergo the protocol review process, but if undertaken it is conducted at the company’s own risk, as medical devices do today. Clearly, however, I’m not advocating for the dismantling of DSHEA. Those who are happy with it may continue down that path. Rather, this is a system that could be in addition to DSHEA for those companies desiring to make truthful and non-misleading claims for age-related health conditions and diseases.

    Regardless, there is one amendment to DSHEA we should all agree on. This is to reset the grandfathered date for ingredients under DSHEA; the amendment would require FDA to promulgate a list within one year based on labels provided by the industry. In addition, this amendment should clarify that synthetic botanicals that are truly synthetic versions of natural constituents are permissible dietary ingredients.  

    Finally, we should also revise the civil investigation rules for the FTC to require it to disclose in detail why it believes a company’s claims are not substantiated prior to seeking an action. It should also provide the company adequate time to respond directly to the commissioners tasked with the responsibility of deciding whether to move forward should the company decide not to settle.  

    These few suggestions are not intended to be all encompassing. Rather, they’re intended to be food for thought on how we may bring about disruptive legislation that would actually improve the regulatory framework and benefit American consumers. We have at least two years for out-of-the-box thinking. The question here lays in whether the industry is ready to be disruptive by proposing disruptive legislation that makes sense and will benefit everyone. 


    Todd Harrison
    Venable

    Todd Harrison is partner with Venable, which is located in Washington, D.C. He advises food and drug companies on a variety of FDA and FTC matters, with an emphasis on dietary supplement, functional food, biotech, legislative, adulteration, labeling and advertising issues. He can be reached at 575 7th St. NW, Washington, D.C. 20004, Tel: 202-344-4724; E-mail: taharrison@venable.com.
    Related Searches
    • Adulteration
    • Polyphenols
    • Medical Food
    • Nutritional
    Related Knowledge Center
    • Quality & Safety
    • Healthcare Trends
    • Dietary Supplements
    • Regulations
    Suggested For You
    House Reps Try Again to Regulate CBD and Other Hemp Derivatives as Dietary Ingredients House Reps Try Again to Regulate CBD and Other Hemp Derivatives as Dietary Ingredients
    CBD Expectations: What Happens at FDA and Congress After Agency Seeks New Regulatory Pathway? CBD Expectations: What Happens at FDA and Congress After Agency Seeks New Regulatory Pathway?
    Regulatory Challenges Persist for Dietary Supplement Stakeholders Regulatory Challenges Persist for Dietary Supplement Stakeholders
    Is It Time for a ‘New FDA’ to Regulate Food and Dietary Supplements? Is It Time for a ‘New FDA’ to Regulate Food and Dietary Supplements?
    Ingestible Beauty Arrives in China Ingestible Beauty Arrives in China
    Senate HELP Committee Advances Bill with Supplement Provisions That Industry Trade Groups Oppose Senate HELP Committee Advances Bill with Supplement Provisions That Industry Trade Groups Oppose
    Pharmactive Enters Partnership with Nutraconnect for APAC Sales Pharmactive Enters Partnership with Nutraconnect for APAC Sales
    Dietary Supplements Are Regulated, and Chronic Stress Has Been Normalized Dietary Supplements Are Regulated, and Chronic Stress Has Been Normalized
    Dietary Supplement Listing Bill Introduced in Senate Dietary Supplement Listing Bill Introduced in Senate
    American College of Clinical Pharmacology Calls for More Regulatory Oversight of Dietary Supplements American College of Clinical Pharmacology Calls for More Regulatory Oversight of Dietary Supplements
    Biden Nominates Dr. Robert Califf to Lead FDA Biden Nominates Dr. Robert Califf to Lead FDA
    FDA Rejects Two New Dietary Ingredient Notifications for CBD FDA Rejects Two New Dietary Ingredient Notifications for CBD
    Legislation to Create Regulatory Pathways for CBD Use in Foods and Supplements Introduced Legislation to Create Regulatory Pathways for CBD Use in Foods and Supplements Introduced
    Open Book Extracts to Support Validcare CBD Safety Trial Open Book Extracts to Support Validcare CBD Safety Trial
    U.K. CBD Market Booms During Lockdown U.K. CBD Market Booms During Lockdown

    Related Breaking News

    • Breaking News | Herbs & Botanicals | Regulations | Regulatory News
      House Reps Try Again to Regulate CBD and Other Hemp Derivatives as Dietary Ingredients

      House Reps Try Again to Regulate CBD and Other Hemp Derivatives as Dietary Ingredients

      After FDA punted CBD back to Congress in January, two House members are floating a pair of bills on the hill.
      03.20.23

    • Dietary Supplements | Herbs & Botanicals | Regulations
      CBD Expectations: What Happens at FDA and Congress After Agency Seeks New Regulatory Pathway?

      CBD Expectations: What Happens at FDA and Congress After Agency Seeks New Regulatory Pathway?

      Stakeholders disappointed by agency inaction but welcome chance to influence legislation.
      By Sean Moloughney, Editor 01.31.23

    • Dietary Supplements | Regulations
      Regulatory Challenges Persist for Dietary Supplement Stakeholders

      Regulatory Challenges Persist for Dietary Supplement Stakeholders

      Experts discussed structure-function claims, drug preclusion issues, and more at AHPA’s Regulatory Congress.
      By Mike Montemarano, Associate Editor 12.20.22


    • Dietary Supplements | Herbs & Botanicals | Quality & Safety | Regulations
      Is It Time for a ‘New FDA’ to Regulate Food and Dietary Supplements?

      Is It Time for a ‘New FDA’ to Regulate Food and Dietary Supplements?

      Proposed legislation aims to create a new agency that would assume responsibilities for the regulation of food and dietary supplements currently held by FDA.
      By Michael McGuffin, President, American Herbal Products Association (AHPA) 09.13.22

    • Consumer Trends | Cosmeceuticals / Nutricosmetics | Healthcare Trends | Minerals | Regulations | Skin Health | Vitamins | World Markets
      Ingestible Beauty Arrives in China

      Ingestible Beauty Arrives in China

      Demand soars as regulations become clearer and younger consumers have an appetite for tablets, capsules, and drinks.
      By Ally Dai, Contributing Writer 09.01.22

    Loading, Please Wait..
    Trending
    • Shiitake Mushroom Extract Appears Helpful In HPV Infections
    • The Functional Chocolate Company Launches Painfree Chocolate
    Breaking News
    • NPA: ‘Major Victory’ in Colorado After Amendment to Eating Disorder Bill
    • GOOD Meat Receives FDA Go-Ahead for Cultured Meat
    • IFF Achieves Industrial-Scale Production of Anaerobic Probiotic Strain
    • Jones Healthcare Group Primed to Help Nutraceutical Brands Comply with New Packaging Rules
    • Nordic Naturals Debuts Probiotic Line in More Than 375 Sprouts Farmer’s Markets
    View Breaking News >
    CURRENT ISSUE

    March 2023

    • Supporting Musculoskeletal Health: Tending to Muscles, Joints, and Bones
    • Dosage and Delivery Innovations Help Manufacturers Meet Common Challenges
    • 2023 Contract Manufacturing Survey
    • Manufacturing Dietary Supplements in Economic Uncertainty
    • Beyond Antioxidants: The Power of Berries
    • A Paradigm Shift for Antioxidants?
    • Ayana Bio on Path to Scale Bioactives Derived from Plant Cell Cultures
    • Nuritas: Leveraging Artificial Intelligence to Speak the Language of Life
    • Dietary Supplement Quality Assurance Programs Critical to Natural Products Industry Success
    • Innovation in Nutraceuticals: Dose Forms and Application Science Help Meet Consumer Demand
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    NPA: ‘Major Victory’ in Colorado After Amendment to Eating Disorder Bill
    GOOD Meat Receives FDA Go-Ahead for Cultured Meat
    IFF Achieves Industrial-Scale Production of Anaerobic Probiotic Strain
    Coatings World

    Latest Breaking News From Coatings World

    HOFFMANN MINERAL to Focus on Comprehensive Sustainability Strategy
    HMG and Prodrive Renew Technical Partnership
    Eastern Coatings Show Sets Schedule for Technical Papers
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most-Read Stories This Week—March 25
    Getinge iCast Receives FDA Premarket Approval
    Tessy Plastics Corp. Celebrates 50th Anniversary
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Willow, Suanfarma Complete Manufacturing Process for Cannabigerol
    Berkshire Sterile to Install nearly 1,500 solar panels at Massachusetts site
    Harm Reduction Therapeutics, Catalent Ink Naloxone Commercial Supply Pact
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Interpack 2023 Introduces New Special Areas and Activities
    eSalon Expands into Over 1,900 CVS Stores Nationwide
    The RealReal Discontinues Beauty Business
    Happi

    Latest Breaking News From Happi

    Clairol Announces First Global Haircare Campaign in Five Years
    Nair’s Prep & Smooth Hair Removal, Walmart’s Accelerator
    ‘Glossier You’ Returns to Glossier’s Fragrance Portfolio
    Ink World

    Latest Breaking News From Ink World

    Weekly Recap: Packaging Inks, Toyo Ink Top This Week’s Stories
    Eastern Coatings Show Announces Schedule for Technical Papers
    Pulse Roll Label Products Adds Sean Labas to Technical Sales Team
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Imageworx details new facility, Avery Dennison tackles recycling and more
    TLMI announces 2022 Eugene Singer Award winners
    Pulse Roll Label Products expands technical sales team
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Weekly Recap: Heartland Polymers Begins Production, Zeta Polimeri Becomes Radici EcoMaterials & More
    Heartland Polymers Begins Production in Alberta
    Zeta Polimeri Becomes Radici EcoMaterials
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—March 25
    AI is Effective at Documenting Orthopedic Encounters in Hand Surgery
    3D LifePrints Rebrands to Insight Surgery & Launches New Business in Houston
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: Dave Rahami, Zebra, Dracula Technologies Top This Week’s Stories
    Midsummer, UCLA Collaborate on Perovskite-CIGS Tandem Solar Cells
    HID Reports on Reshaping the Security Industry

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login